We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
One Million Lives Saved Per Year: A Cost–Benefit Analysis of the Global Plan to End Tuberculosis, 2023–2030 and Beyond.
- Authors
Pretorius, Carel; Arinaminpathy, Nimalan; Mandal, Sandip; Sahu, Suvanand; Pai, Madhukar; Mathiasson, Roland; Wong, Brad
- Abstract
This report presents a cost–benefit analysis of increased spending on tuberculosis (TB) using impacts and costs drawn from the Global Plan to End Tuberculosis, 2023–2030. The analysis indicates that the return on TB spending is substantial with a centrally estimated benefit–cost ratio (BCR) of 46, meaning every US$ 1 invested in TB yields US$ 46 in benefits. Alternative specifications using different baselines, interventions, cost profiles, and discount rates still yield robustly high BCRs, in the range of 28–84. This report also shows that TB investment would avert substantial mortality, estimated at 27.3 million averted deaths over the 28-year period between 2023 and 2050 inclusive: almost 1 million averted deaths per year on average. Accounting for all estimated direct and indirect costs, the cost per averted death is slightly over US$ 2000. Interventions to address TB represent exceptional value-for-money.
- Subjects
COST benefit analysis; TUBERCULOSIS patients; TUBERCULOSIS; DISCOUNT prices; DIRECT costing
- Publication
Journal of Benefit-Cost Analysis, 2023, Vol 14, p337
- ISSN
2152-2812
- Publication type
Article
- DOI
10.1017/bca.2023.13